Medical device company TransEnterix is closing in on a $15 million round of fundraising as the firm continues to build sales for its minimally invasive surgical system. Securities filings show that TransEnterix has raised $14.9 million in the equity round, which opened on November 30 and included participation from nine investors. Including the current fundraising round, TransEnterix’s venture capital haul is more than $75 million. Investors in the Research Triangle Park, North Carolina company include Aisling Capital, Intersouth Partners, Quaker Partners, SV Life Science Advisers, Synergy Life Science Partners and Parish Capital Advisors.
